{
    "name": "Authorized sources of medical cannabis",
    "number": "130",
    "text": "(a)\u00a0 After December 31, 2023, a qualifying patient shall obtain medical cannabis or manufactured cannabis products only:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 From a dispensary licensed pursuant to chapter 329D; provided that the cannabis shall be purchased and paid for at the time of purchase; or\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 By cultivating cannabis in an amount that does not exceed an adequate supply for the qualifying patient, pursuant to section 329-122; provided that each location used to cultivate cannabis shall be used by no more than five qualifying patients.\nAfter December 31, 2023, no primary caregiver shall be authorized to cultivate cannabis for any qualifying patient.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 This section shall not apply to:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 A qualifying patient who is a minor or an adult lacking legal capacity and the primary caregiver is the parent, guardian, or person having legal custody of a qualifying patient described in this paragraph; or\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 A qualifying patient on any island on which there is no medical cannabis dispensary licensed pursuant to chapter 329D. [L 2015, c 241, pt of \u00a75; am L 2017, c 41, \u00a74 and c 170, \u00a72]\n\u00a0\nRevision Note\n\u00a0\n\u00a0 In subsection (a), \"marijuana\" changed to \"cannabis\" to conform to L 2017, c 170, pursuant to \u00a723G-15."
}